Bioventus (BVS) EBT Margin Growth (3y) (2023 - 2026)
Bioventus (BVS) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 423.00 |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn | 1,317.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 1,317.00 |
| Mar 28, 2026 | 8,755.00 |
| Dec 31, 2025 | 3,474.00 |
| Sep 27, 2025 | 10,484.00 |
| Jun 28, 2025 | 1,161.00 |
| Mar 29, 2025 | 1,390.00 |
| Dec 31, 2024 | 207.00 |
| Sep 28, 2024 | -89.00 |
| Jun 29, 2024 | -1,923.00 |
| Mar 30, 2024 | -3,413.00 |
| Dec 31, 2023 | -939.00 |
| Sep 30, 2023 | -1,649.00 |
| Jul 1, 2023 | 732.00 |
| Apr 1, 2023 | -9,751.00 |